This case-control study was carried out to compare serum total antioxidant capacity (TAC) in the newly diagnosed children with epilepsy and that of a control group of healthy children at the same age and probable effects of antiseizure medications prescription on it.
Introduction
Seizures and epileptic syndromes are common in children. 10 Serum concentrations of enzymatic antioxidants could be measured, but these measurements are time-consuming, expensive and require complex techniques, therefore, we carried out a study to measure serum total antioxidant capacity (TAC) with a more practical method in a group of children with newly diagnosed epilepsy before therapy and to compare this capacity by that of a group of ageand sex-matched healthy controls.
Materials & Methods

Study design
We carried out this case-control study to compare serum TAC in children with newly diagnosed epilepsy (either outpatients or inpatients) and that of a group of sex-and age-matched healthy controls. The effect of anticonvulsant monotherapy on the serum TAC also was studied in children with epilepsy before and 3 months after anticonvulsant monotherapy. The study was conducted in 
Blood sample collection
Blood samples were drawn by venipuncture from the antecubital vein using a disposal plastic syringe through a 23-gauge needle in the morning between 8:00 and 11:00 am. Subjects fasted for 8 h before sample collection. All children with epilepsy were at least 24 h seizure-free before the sampling time.
Samples were transferred to the laboratory within 2 h for biochemical analysis.
Biochemical analyses
Blood samples were centrifuged at 1500 × gr for 10 min, and the serum was We also assessed serum albumin, total bilirubin, and uric acid as nonenzymatic antioxidants in each group. Albumin and uric acid were measured spectrophotometric method (using Bromocresol green and uricase reactant, respectively). Bilirubin was measured with dichloroaniline method. All spectrophotometric assays performed on Hitachi 717 autoanalyzer.
Statistical analysis
A significant difference in the serum total antioxidant capacity between two groups was expected (power=80%, α=0.05, β=0.2). All data were reported as the means (SD 
Results
One hundred and thirty participants (65 in each group) aged 1 to 17 yr were enrolled in this study.
Generalized tonic-clonic seizures consisted of 50 cases (77%) and other seizure types were 8 (12.3%) with complex partial seizures (CPS), 4(6.1%) with simple partial seizure (SPS) and 3 (4.6%) with atonic seizure. In the patient's group, 15 were given phenobarbital monotherapy, 26
were given sodium valproate monotherapy, and 24 received carbamazepine monotherapy. We found no significant differences between the groups regarding gender distribution or mean age ( Table 1 ).
The serum levels of total antioxidant capacity and nonenzymatic antioxidant parameter of the participants before AED administration are shown in Table 2 . TAC was significantly lower in the patients with newly diagnosed epilepsy than that of the controls (P <0.001). Serum albumin and uric acid levels were not significantly different in the patients from the control, but serum total bilirubin was significantly lower in the patients with newly diagnosed epilepsy than that of the controls (P <0.001).
Serum Total Antioxidant Capacity of Epileptic Children before and after Monotherapy with Sodium Valproate... months. Serum total bilirubin and uric acid were significantly different in study groups (Table 3 ).
There were also no significant differences in total antioxidant capacity of the patients, before and 3 months after anticonvulsant administration based on the treatment groups (Table 4) .
Serum Total Antioxidant Capacity of Epileptic Children before and after Monotherapy with Sodium Valproate... The serum total antioxidant capacity levels were lower in the untreated group comparing to controls.
However, no significant difference was found in the serum total antioxidant capacity of sodium valproate, carbamazepine or phenobarbital monotherapy group and that of the controls (5). However, after treatment, serum total antioxidant capacity was significantly lower in children who received sodium valproate or carbamazepine. Both monotherapy and polytherapy did not change oxidative stress parameters in epileptic patients (14) .
We also measured serum albumin, serum total bilirubin and uric acid in our participants. These are well-known endogenous antioxidant molecules in the serum (10) . Uric acid concentrations were higher in untreated adults with epilepsy. There were also high uric acid concentrations in patients who treated with sodium valproate monotherapy(4). In our study, uric acid concentrations were significantly higher in children treated with phenobarbital than to the controls and other treatment groups. We also found that in children who received carbamazepine, uric acid concentrations were significantly lower than to controls and sodium valproate group.
The serum uric acid concentrations were lower in the sodium valproate monotherapy group than that of the untreated group. The serum bilirubin concentration was higher in the untreated epileptics than that of the controls, and albumin was lowter in the sodium valproate group than that of the controls (5). In our study, serum albumin had no difference between treatment groups and controls.
Moreover, serum total bilirubin was significantly higher in the controls than to sodium valproate and phenobarbital groups. We have no idea for these inconsistencies between our results and previous studies, but dietary habits and age of study population could be an explanation for these differences.
Change in nonenzymatic antioxidant levels may be a protective mechanism against decreased total antioxidant capacity (5, 16). However, our results did not support this hypothesis and nonenzymatic antioxidants had no significant increased serum levels in our patients.
The results of our study must be interpreted in the face of certain limits. In this study, only serum 6. Ergul Belge Kurutas The importance of antioxidants, which play the role in cellular TAC and nonenzymatic antioxidant levels of the subjects were evaluated and the assessment of lipid peroxidation as the main oxidative marker of the oxidative stress was not performed. Another limit of our study was that at the beginning of the study we lost some of our patients. Therefore, we decided to have a short follow up and we narrowed the study to a short period of 3 months after anticonvulsant administration.
In conclusion, reduced serum total antioxidant capacity and an increased vulnerability to oxidative stress should be considered in the children with epilepsy and may have an etiologic role. Beneficial effect of nutritional supplements was reported in several studies. Further studies on this subject are needed, along with a search for new anticonvulsants with antioxidant properties.
